| Product Name | MF | CAS | Details |
|---|
| DHX16 Blocking Peptide | Details |
| 3-Bromo-2-chloro-6-fluorobenzyl alcohol | C7H5BrClFO | 1784628-56-3 | Details |
| 2-[3-Cyclopropyl-6-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]acetic acid | C18H14F3N3O2 | 937606-06-9 | Details |
| Hyaluronate fluorescein - Molecular Weight - 20kDa | Details |
| 2-[4-(2-Hydroxyethoxy)phenyl]acetonitrile | C10H11NO2 | 73864-61-6 | Details |
| 4-(Trifluoromethyl)-1,2,3,4-tetrahydroquinoline | C10H10F3N | 1423030-95-8 | Details |
| 1H-Indole-7-carboxamide | C9H8N2O | 1670-89-9 | Details |
| MEK2 antibody (Thr394) | Details |
| H-NPNQNKNVAL-OH | Details |
| N-Desalkyl itraconazole | C31H30Cl2N8O4 | 89848-41-9 | Details |
| 2,5-Dimethyl-7,7,8,8-tetracyanoquinodimethane | C14H8N4 | 1487-82-7 | Details |
| 6-Bromo-1-methyl-1H-indole | C9H8BrN | 125872-95-9 | Details |
| Human HSP27 ELISA Kit | Details |
| Ethyl 2-{[(tert-butoxy)carbonyl]amino}-3-(4-chlorophenyl)-3-hydroxypropanoate | C16H22ClNO5 | 2044712-60-7 | Details |
| (R)-(+)-3-Aminoquinuclidine dihydrochloride | C7H16Cl2N2 | 123536-14-1 | Details |
| 1-N-Cyclopropyl-3-fluorobenzene-1,2-diamine | C9H11FN2 | 1179208-96-8 | Details |
| Methyl 5-bromo-2-methylisonicotinate | C8H8BrNO2 | 1804406-76-5 | Details |
| EIF4A2 antibody (biotin) | Details |
| 6-Chloro-8-(2-chloroethyl)-3,4-dihydro-2H-1,5-benzodioxepine | C11H12Cl2O2 | 1339128-13-0 | Details |
| 3-Methyl-2-(2-methyl-1H-1,3-benzodiazol-1-yl)butanoic acid | C13H16N2O2 | 1016703-24-4 | Details |
| ASPA protein (His tag) | Details |
| 2-(2-Methyloxolan-2-yl)piperidine hydrochloride | 2287289-19-2 | Details |
| 2-Cyclohexylmorpholine | C10H19NO | 1251196-25-4 | Details |
| 1,2-Dibromobutane | C4H8Br2 | 533-98-2 | Details |
| (Quinolin-5-yl)methanesulfonamide | C10H10N2O2S | 1566333-08-1 | Details |
| MKLN1 antibody | Details |
| 2'-Amino-2'-deoxycytidine | C9H14N4O4 | 26889-42-9 | Details |
| NFKP p65 antibody (Ser276) | Details |
| H-NPANNAAIVLQLPQGTTLPK-OH | Details |
| H-ELINNELSHFLEEIK^-OH | Details |
| H-SLLNNQFGTM-OH | Details |
| ethyl 4-(N-butylcarbamoyl)piperazinecarboxylate | C12H23N3O3 | 1024140-18-8 | Details |
| 6-(Oxetan-3-yloxy)pyridin-3-amine | C8H10N2O2 | 1349716-84-2 | Details |
| 3,5-Dibromothiophene-2-carboxylic acid | C5H2Br2O2S | 7311-68-4 | Details |
| MAP2K7 antibody | Details |
| 1-Chloro-2-(2-ethoxyethoxy)ethane | C6H13ClO2 | 41771-35-1 | Details |
| (+)-Sylvatesmin | C21H24O6 | 487-39-8 | Details |
| Anti-FGFR2c antibody - 1mg/mL | Details |
| N6-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-MMT-adenosine 3'-CE phosphoramidite | C52H64N7O7PSi | Details |
| 4-(Morpholinocarbonyl)benzylamine | C12H16N2O2 | 923138-47-0 | Details |
| UNC 2400 | C35H47N7O2 | 1433200-49-7 | Details |
| p-Methoxybenzylmercaptan | C8H10OS | 6258-60-2 | Details |
| 8-Methoxy-4-methyl-5,12-dithia-3-azatricyclo[7.3.0.0,2,6]dodeca-1(9),2(6),3,7,10-pentaene | C11H9NOS2 | 313953-19-4 | Details |
| Methyl 5-(aminomethyl)pyridine-3-carboxylate dihydrochloride | C8H12Cl2N2O2 | 1006619-16-4 | Details |
| Tel antibody | Details |
| 2-Amino-2-(2-methylcyclopropyl)acetic acids | C6H11NO2 | 89531-26-0 | Details |
| NT5M Blocking Peptide | Details |
| N-Ethyl-glycine hydrochloride | C4H10ClNO2 | 542-53-0 | Details |
| Acetylseneciphylline N-oxide | C20H25NO7 | 123844-00-8 | Details |
| Iodo(methanesulfonyl)methane | C2H5IO2S | 798568-07-7 | Details |
| 3-(2,3-Dihydro-1,4-benzodioxine-6-sulfinyl)propanoic acid | C11H12O5S | 1334012-17-7 | Details |
| 7-Chloro-4-methyl-1H-indole-2-carboxylic acid | C10H8ClNO2 | 1388043-92-2 | Details |
| 5-(Methoxymethyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-ol | C9H11N3O2 | 439111-05-4 | Details |
| Phenyl trifluoromethylsulfone | C7H5F3O2S | 426-58-4 | Details |
| Daunorubicinol | C27H31NO10 | 28008-55-1 | Details |
| Benzylurea | C8H10N2O | 538-32-9 | Details |
| 3',5'-Dichloro-2'-hydroxyacetophenone | C8H6Cl2O2 | 3321-92-4 | Details |
| 3-Hydroxy-N-(5-methyl-1,3-thiazol-2-yl)benzamide | C11H10N2O2S | 1019453-02-1 | Details |
| (E)-2-Decene-1,10-dioic acid | C10H16O4 | 37443-67-7 | Details |
| 3'-Amino-2',3'-dideoxy-5'-O-toluoyluridine | C17H19N3O5 | Details |
| 3-Amino-1H-indole-2-carbonitrile | C9H7N3 | 1192690-93-9 | Details |
| 6-Methoxypyrimidine-4-carboxylic acid | C6H6N2O3 | 38214-45-8 | Details |
| 2-Oxabicyclo[2.2.2]octane-4-carbaldehyde | C8H12O2 | 1212021-23-2 | Details |
| Methyl 4,6-dimethoxy-1H-indole-2-carboxylate | C12H13NO4 | 105776-13-4 | Details |
| FGF1 protein | Details |
| (2S,3S)-3-Methyl-2-[(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)formamido]pentanoic acid | C13H18N2O4 | 1807896-11-2 | Details |
| Gibberellin-BSA | Details |
| Bis(o-ethylbenzylamine) catechol dihydrochloride | C24H30Cl2N2O2 | 340963-59-9 | Details |
| Dichlorodiisopropylsilane | C6H14Cl2Si | 7751-38-4 | Details |
| 3-Methyl-1-(pyridin-4-yl)-1H-1,2,4-triazol-5-amine | C8H9N5 | 1247374-68-0 | Details |
| 1-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)-2,2,2-trifluoroethan-1-one | C15H14F3NO | 1803608-26-5 | Details |
| SERBP1 Blocking Peptide | Details |
| AK778 | C28H22N4O3 | 328906-67-8 | Details |
| 7-Fluoro-1,3-benzothiazole-2-carbaldehyde | C8H4FNOS | 1784001-90-6 | Details |
| Perfluorohexylphosphonic acid | C6H2F13O3P | 40143-76-8 | Details |
| [1-(But-3-en-1-yl)cyclopentyl]methanamine | C10H19N | 1335044-30-8 | Details |
| 6-Methyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2-carbaldehyde | C9H11NOS | 1343764-35-1 | Details |
| Tropacocaine | C15H19NO2 | 537-26-8 | Details |
| (6-((2-(3,4-dimethoxyphenyl)ethyl)amino)-2-oxo-4-phenylcyclohex-1-enyl)-N-benzamide | C29H30N2O4 | 1022237-85-9 | Details |
| 2-Hydroxy-5-nitrobenzohydrazide | C7H7N3O4 | 946-32-7 | Details |
| 6-?Oxa-?2-?thiaspiro[4.5]?decan-?9-?amine 2,?2-?dioxide hydrochloride | C8H16ClNO3S | 1444025-85-7 | Details |
| 2-(4-(tert-butyl)phenoxy)(3-pyridyl) 4-phenylpiperazinyl ketone | C26H29N3O2 | 497060-68-1 | Details |
| Methyl (4S)-b-cellobiosyl-4-thio-b-cellobioside | C25H44O20S | 205451-26-9 | Details |
| 3-(Chloromethyl)-N-(2-methylpropyl)benzamide | C12H16ClNO | 1094268-39-9 | Details |
| MAP3K1 antibody (FITC) | Details |
| 2,3,5-Trifluorophenylacetic acid | C8H5F3O2 | 132992-28-0 | Details |
| UBE4B Blocking Peptide | Details |
| 4,9-Anhydrotetrodotoxin | C11H15N3O7 | 13072-89-4 | Details |
| 3-(Pyrrolidine-1-sulfonyl)benzohydrazide | C11H15N3O3S | 328028-06-4 | Details |
| 4-(3-Methylphenyl)-1,2,3,4-tetrahydroquinoxalin-2-one | C15H14N2O | 1894460-53-7 | Details |
| Succinyl-gamma-cyclodextrin | Details |
| rac-(1R,2R)-2-(3,4-Dimethylphenyl)cyclopropane-1-carboxylic acid | C12H14O2 | 220353-13-9 | Details |
| 4-(Methoxycarbonyl)benzene-1-sulfinic acid | C8H8O4S | 110955-49-2 | Details |
| [2-(3-Methoxyphenyl)ethyl][(1-methyl-1H-pyrazol-5-yl)methyl]amine | C14H19N3O | 1171807-81-0 | Details |
| 5-(3-Methylfuran-2-yl)-1,3,4-thiadiazol-2-amine | C7H7N3OS | 1019527-96-8 | Details |
| (3-Methylbutoxy)benzene | C11H16O | 1129-64-2 | Details |
| Normal Syrian Hamster Serum | Details |
| 1-[(2-Fluorophenyl)methyl]-1H-1,2,4-triazol-3-amine | C9H9FN4 | 832740-23-5 | Details |
| H-S^LSLSPGK^-OH | Details |
| N4-Benzoyl-5'-O-Trityl-cytidine | C35H31N3O6 | 41092-41-5 | Details |
| Product Total： Product Page： | ||||
| 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 | ||||